dihydroxyphenylalanine has been researched along with Digestive System Neoplasms in 2 studies
Dihydroxyphenylalanine: A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific.
dopa : A hydroxyphenylalanine carrying hydroxy substituents at positions 3 and 4 of the benzene ring.
Digestive System Neoplasms: Tumors or cancer of the DIGESTIVE SYSTEM.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Conversely, in noncarcinoid tumors, the extent of the disease was more accurately evaluated in all cases by (111)In-pentetreotide SRS than by (18)F-FDOPA PET." | 1.33 | Can fluorodihydroxyphenylalanine PET replace somatostatin receptor scintigraphy in patients with digestive endocrine tumors? ( Aide, N; de Beco, V; Grahek, D; Grangé, JD; Gutman, F; Kerrou, K; Lotz, JP; Montravers, F; Ruszniewski, P; Talbot, JN, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Montravers, F | 1 |
| Grahek, D | 1 |
| Kerrou, K | 1 |
| Ruszniewski, P | 1 |
| de Beco, V | 1 |
| Aide, N | 1 |
| Gutman, F | 1 |
| Grangé, JD | 1 |
| Lotz, JP | 1 |
| Talbot, JN | 1 |
| Ambrosini, V | 1 |
| Tomassetti, P | 1 |
| Rubello, D | 1 |
| Campana, D | 1 |
| Nanni, C | 1 |
| Castellucci, P | 1 |
| Farsad, M | 1 |
| Montini, G | 1 |
| Al-Nahhas, A | 1 |
| Franchi, R | 1 |
| Fanti, S | 1 |
1 trial available for dihydroxyphenylalanine and Digestive System Neoplasms
| Article | Year |
|---|---|
Role of 18F-dopa PET/CT imaging in the management of patients with 111In-pentetreotide negative GEP tumours.
Topics: Adult; Aged; Aged, 80 and over; Biopsy, Needle; Digestive System Neoplasms; Dihydroxyphenylalanine; | 2007 |
1 other study available for dihydroxyphenylalanine and Digestive System Neoplasms
| Article | Year |
|---|---|
Can fluorodihydroxyphenylalanine PET replace somatostatin receptor scintigraphy in patients with digestive endocrine tumors?
Topics: Adult; Aged; Carcinoid Tumor; Digestive System Neoplasms; Dihydroxyphenylalanine; Endocrine Gland Ne | 2006 |